SUPPORT HOTLINE 888-901-2226
Donate Now

New Guidelines for Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer!

For the first time for any type of malignancy, the American Urological Association (AUA), the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), and the Society of Urologic Oncology (SUO) have formulated an evidence-based guideline for the treatment of non-metastatic muscle-invasive bladder cancer. BCAN Co-Founder, Diane Z. Quale represented patients on the panel of experts that recognized the importance of multidisciplinary collaborative efforts that take into account survival and quality-of-life (QOL) concerns, as they developed the guidelines.

Read the new guidelines